The information and comments on this site are intended for educational purposes only. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Anyone suffering from any disease, illness or injury should consult with a physician. These suggested uses apply only to the use of therapeutic grade, Young Living essential oils.

Wednesday, February 10, 2016

Erin Brockovich~ Facebook post on Johnson & Johnson Baby powder and other talc products

"This is scary... we have been taught for generations this stuff is "safe'... and marketed for our babies.

An increasing number of lawsuits name consumer health care giant Johnson & Johnson, who has sold Johnson’s Baby Powder for more than a century, and currently markets other brands including Shower to Shower. The lawsuits claim that studies dating back 30 years or more have drawn a link between talcum powder and ovarian cancer.

Studies suggest that about 10 percent – or as many as 2,000 – of ovarian cancer cases diagnosed each year could be linked to genital use of talcum powder. Johnson & Johnson was even contacted by a researcher who alerted the company to the cancer risk with its talc-containing products and urged them to warn consumers, but the company refused.

The theory is that talc, when applied to the genitals, can travel up the uterus, through the fallopian tubes and into the ovaries where it can inflame tissue and trigger cancerous growth. In fact, during the first and only talcum powder ovarian cancer lawsuit to go to trial the plaintiff attorney brought evidence from three researchers who looked at the cancerous tissue removed from the plaintiff and found bits of talc. The woman claimed daily and long-term use of Johnson’s Shower to Shower caused her to develop ovarian cancer. The jury found in her favor and agreed that the company should have warned consumers of this risk."

If you have any questions or concerns... please email me directly and I can help you find answers. erin@brockovich.com

No comments: